BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 26503496)

  • 1. Heat stroke during treatment with olanzapine, trihexyphenidyl, and trazodone in a patient with schizophrenia.
    Lee CP; Chen PJ; Chang CM
    Acta Neuropsychiatr; 2015 Dec; 27(6):380-5. PubMed ID: 26503496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amisulpride versus olanzapine in the treatment of schizophrenia in Indian patients: randomized controlled trial.
    Bhowmick S; Hazra A; Ghosh M
    Aust N Z J Psychiatry; 2010 Mar; 44(3):237-42. PubMed ID: 20050717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EEG abnormalities under treatment with atypical antipsychotics: effects of olanzapine and amisulpride as compared to haloperidol.
    Pogarell O; Juckel G; Mulert C; Amann B; Möller HJ; Hegerl U
    Pharmacopsychiatry; 2004 Nov; 37(6):304-5. PubMed ID: 15551199
    [No Abstract]   [Full Text] [Related]  

  • 4. Augmentation treatment with amisulpride in schizophrenic patients partially responsive to olanzapine.
    Molina JD; Toledo-Romero F; López-Rodríguez E; Amorin-Díaz M; Lerma-Carrillo I; López-Muñoz F
    Pharmacopsychiatry; 2011 Jun; 44(4):142-7. PubMed ID: 21710404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent heat-related illnesses during antipsychotic treatment.
    Kwok JS; Chan TY
    Ann Pharmacother; 2005 Nov; 39(11):1940-2. PubMed ID: 16174785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive improvement in schizophrenic patients does not require a serotonergic mechanism: randomized controlled trial of olanzapine vs amisulpride.
    Wagner M; Quednow BB; Westheide J; Schlaepfer TE; Maier W; Kühn KU
    Neuropsychopharmacology; 2005 Feb; 30(2):381-90. PubMed ID: 15578006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind, randomised comparative trial of amisulpride versus olanzapine in the treatment of schizophrenia: short-term results at two months.
    Martin S; Lĵo H; Peuskens J; Thirumalai S; Giudicelli A; Fleurot O; Rein W;
    Curr Med Res Opin; 2002; 18(6):355-62. PubMed ID: 12442883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Atypical neuroleptics: new approaches to drug therapy of schizophrenic disorders].
    Hilger E; Kasper S
    Wien Klin Wochenschr; 2000 Dec; 112(24):1031-8. PubMed ID: 11204312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind, randomized comparative trial of amisulpride versus olanzapine for 6 months in the treatment of schizophrenia.
    Mortimer A; Martin S; Lôo H; Peuskens J;
    Int Clin Psychopharmacol; 2004 Mar; 19(2):63-9. PubMed ID: 15076013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Incompatibility of olanzapine and amisulpride in multisystemic myotonic myopathy].
    Pedrosa Gil F; Schneider C; Grohmann R; Rüther E
    Nervenarzt; 2001 Sep; 72(9):729-33. PubMed ID: 11572107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic control in patients with schizophrenia treated with amisulpride or olanzapine.
    Peuskens J; De Hert M; Mortimer A;
    Int Clin Psychopharmacol; 2007 May; 22(3):145-52. PubMed ID: 17414740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with amisulpride and olanzapine improve neuropsychological function in schizophrenia.
    Mortimer AM; Joyce E; Balasubramaniam K; Choudhary PC; Saleem PT;
    Hum Psychopharmacol; 2007 Oct; 22(7):445-54. PubMed ID: 17691076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do differences in atypical antipsychotics matter in routine practice? Medication switch from olanzapine and risperidone to amisulpride.
    Linden M; Eich FX; Pyrkosch L
    Int Clin Psychopharmacol; 2007 May; 22(3):175-8. PubMed ID: 17414744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacodynamic and pharmacokinetic factors in a case of neuroleptic malignant syndrome.
    Shad MU; Preskorn SH
    J Clin Psychopharmacol; 1998 Aug; 18(4):346-7. PubMed ID: 9690705
    [No Abstract]   [Full Text] [Related]  

  • 15. A double-blind randomised comparative trial of amisulpride versus olanzapine for 2 months in the treatment of subjects with schizophrenia and comorbid depression.
    Vanelle JM; Douki S
    Eur Psychiatry; 2006 Dec; 21(8):523-30. PubMed ID: 17113759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prospective observational study of outpatients with schizophrenia in Poland: preliminary 6 month efficacy and tolerability results].
    Meder J; Debowska G; Lis J; Araszkiewicz A; Sierosławska K; Kolesaric A; Treuer T
    Psychiatr Pol; 2004; 38(3):469-84. PubMed ID: 15199656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed Serotonin Syndrome in the Setting of a Mixed Fluoxetine and Serotonin Antagonist Overdose.
    Little K; Lin CM; Reynolds PM
    Am J Case Rep; 2018 May; 19():604-607. PubMed ID: 29795058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olanzapine. Keep an eye on this neuroleptic.
    Can Fam Physician; 2000 Feb; 46():322-6, 330-6. PubMed ID: 10690489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluphenazine (oral) versus atypical antipsychotics for schizophrenia.
    Sampford JR; Sampson S; Li BG; Zhao S; Xia J; Furtado VA
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD010832. PubMed ID: 27370402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second-generation antipsychotic medications and risk of pneumonia in schizophrenia.
    Kuo CJ; Yang SY; Liao YT; Chen WJ; Lee WC; Shau WY; Chang YT; Tsai SY; Chen CC
    Schizophr Bull; 2013 May; 39(3):648-57. PubMed ID: 22282455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.